Search

Minerva Neurosciences Inc

Chiusa

2.27 -5.81

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

2.31

Massimo

2.49

Metriche Chiave

By Trading Economics

Entrata

143M

17M

Dipendenti

7

EBITDA

-11M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+255.65% upside

Dividendi

By Acuity

Utili prossimi

4 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-77M

95M

Apertura precedente

8.08

Chiusura precedente

2.27

Minerva Neurosciences Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

21 ott 2026, 23:56 UTC

Valaris Ltd's shares traded roughly flat during after-market hours, remaining about 10.31% above their 20-day moving average.

21 ott 2026, 23:56 UTC

Omega Flex Inc shares advanced in after-market trading on Wednesday.

21 ott 2026, 23:56 UTC

Akamai Technologies Inc. is trading modestly lower in after-market hours, continuing a decline that has seen the stock fall significantly over the past month.

21 ott 2026, 23:56 UTC

Sarepta Therapeutics Inc's shares are trading higher in after-market hours, following a day of fluctuating returns with prices ranging from a high of 0.48% to a low of -1.58%.

21 ott 2026, 23:56 UTC

CareDx Inc is seeing a modest increase in after-market trading, continuing its upward trend since Wednesday's close and remaining significantly above its 20-day moving average.

21 ott 2026, 23:56 UTC

Rapid7 Inc is trading higher in after-market hours, maintaining a robust gain since Wednesday's close and remaining above its 20-day moving average.

21 ott 2026, 23:56 UTC

Beam Therapeutics Inc shares declined modestly in after-market trading, remaining lower overall since Wednesday's close despite a brief recovery during the session.

21 ott 2026, 23:56 UTC

Correlated Moves

monday.com Ltd shares declined in after-market trading, following a notable drop in Appfolio Inc amid a significant change in momentum.

21 ott 2026, 23:56 UTC

Correlated Moves

Toll Brothers Inc shares declined modestly in after-market trading, influenced by broader market pressure from earnings reports of major holdings like Goldman Sachs and Caterpillar.

21 ott 2026, 23:56 UTC

Baker Hughes Co is trading modestly higher in after-market hours, continuing an upward trajectory that began shortly after the regular session ended.

21 ott 2026, 23:56 UTC

DraftKings Inc. shares are up slightly in after-market trading, maintaining a trend of higher closes over the past three sessions.

21 ott 2026, 23:56 UTC

Tyson Foods Inc. is trading lower in after-market hours, with its cumulative return improving from nearly 0.88% to around 0.23%.

21 ott 2026, 23:56 UTC

MARA Holdings Inc is trading lower in after-market hours, having retraced from earlier gains to its lowest point observed since the market closed.

21 ott 2026, 23:56 UTC

Dynatrace Inc's shares were roughly flat during after-market hours, dipping from a peak but remaining above the 20-day moving average.

21 ott 2026, 23:52 UTC

Celsius Holdings Inc's shares advanced modestly in after-market trading, currently 1.49% above its 20-day moving average and within its one-month range.

21 ott 2026, 23:52 UTC

News

The Nikkei 225 Index is trading modestly lower in after-market hours, following a significant rise earlier in the day amid sector-specific movements.

21 ott 2026, 23:51 UTC

Samsara Inc shares are declining in after-market trading, moving lower alongside the broader market and currently at their lowest point of the day.

21 ott 2026, 23:51 UTC

News

Supernus Pharmaceuticals receives seven years of orphan-drug exclusivity from the FDA for ONAPGO, a treatment for motor fluctuations in advanced Parkinson's disease.

21 ott 2026, 23:51 UTC

Match Group Inc shares are moving lower in after-market hours, declining alongside the broader market and dipping below Wednesday's close.

21 ott 2026, 23:51 UTC

Dlocal Ltd. traded modestly higher during after-market hours on Wednesday, marking a departure from a series of higher daily closes.

21 ott 2026, 23:51 UTC

Red Rock Resorts Inc advanced sharply in after-market trading, recovering from an earlier dip and trading around the middle of its one-month range.

21 ott 2026, 23:51 UTC

Healthequity Inc shares are trading lower in after-market hours, reflecting a broader market decline amid mixed economic signals and fluctuating energy prices.

21 ott 2026, 23:51 UTC

News

Regal Rexnord Corporation declared a quarterly dividend of $0.35 per share, payable on January 14, 2027, to shareholders on record as of December 31, 2026.

21 ott 2026, 23:51 UTC

UDR Inc rose during after-market hours on Wednesday, continuing an upward trend after three consecutive sessions that ended higher.

21 ott 2026, 23:51 UTC

Coeur Mining, Inc. is trading lower in after-market hours, following a broader market downturn, despite an earlier rebound from a session low.

21 ott 2026, 23:51 UTC

OPKO Health Inc is advancing in after-market trading, showing strong upward momentum and positioning the stock above its 20-day moving average.

21 ott 2026, 23:51 UTC

In after-market trading, Nextera Energy Inc shares are modestly lower since Wednesday's close, having fluctuated during the session before retracing.

21 ott 2026, 23:51 UTC

Euro Area Consumer Confidence Flash Forecast at -17.0 Amid Deteriorating Sentiment and Rising Energy Costs

21 ott 2026, 23:51 UTC

Tenet Healthcare Corp shares advanced in after-market trading, maintaining a cumulative return of nearly 1% since Wednesday's close and positioned above its 20-day moving average.

21 ott 2026, 23:51 UTC

GoodRx Holdings Inc is trading higher in after-market hours, recovering from an initial dip and reaching its highest cumulative return of the day.

Confronto tra pari

Modifica del prezzo

Minerva Neurosciences Inc Previsione

Obiettivo di Prezzo

By TipRanks

255.65% in crescita

Previsioni per 12 mesi

Media 8.5 USD  255.65%

Alto 10 USD

Basso 7 USD

Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Minerva Neurosciences Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

2 ratings

1

Acquista

1

Mantieni

0

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Utile prima delle imposte

Vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Minerva Neurosciences Inc

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
help-icon Live chat